Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

2.

Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma.

Chan AC, Chok KS, Yuen WK, Chan SC, Poon RT, Lo CM, Fan ST.

Arch Surg. 2011 Jun;146(6):675-81. doi: 10.1001/archsurg.2011.125.

PMID:
21690443
3.

How does hepatitis B virus infection react to hepatocellular carcinoma treatment?

Wong GL.

J Gastroenterol Hepatol. 2012 Jan;27(1):1-2. doi: 10.1111/j.1440-1746.2011.06950.x. No abstract available.

PMID:
22188022
4.

Quiet reflection after effective action: hepatitis B viraemia and hepatocellular carcinoma recurrence.

Abdo AA, Sanai FM.

Liver Int. 2008 Apr;28(4):423-5. doi: 10.1111/j.1478-3231.2008.01731.x. No abstract available.

PMID:
18339067
5.

Hepatitis B virus DNA and hepatocellular carcinoma recurrence after resection: the lower, the better!

You H, Jia JD.

J Gastroenterol Hepatol. 2010 Dec;25(12):1812-4. doi: 10.1111/j.1440-1746.2010.06516.x. No abstract available.

PMID:
21091989
6.

Antiviral therapy decreases viral reactivation in patients with hepatitis B virus-related hepatocellular carcinoma undergoing hepatectomy: a randomized controlled trial.

Huang L, Li J, Yan J, Sun J, Zhang X, Wu M, Yan Y.

J Viral Hepat. 2013 May;20(5):336-42. doi: 10.1111/jvh.12036. Epub 2012 Dec 5.

PMID:
23565616
7.

Resection of hepatitis B virus-related hepatocellular carcinoma: evolving strategies and emerging therapies to improve outcome.

Chau GY.

World J Gastroenterol. 2014 Sep 21;20(35):12473-84. doi: 10.3748/wjg.v20.i35.12473. Review.

8.

Antiviral therapy in patients with hepatitis B virus-related hepatocellular carcinoma: is it ready for universal application?

Lao XM, Xia HH, Lin XJ, Li SP.

J Viral Hepat. 2013 Dec;20(12):e148-9. doi: 10.1111/jvh.12147. Epub 2013 Jul 17. No abstract available.

PMID:
24304460
9.

Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.

Saab S, Yeganeh M, Nguyen K, Durazo F, Han S, Yersiz H, Farmer DG, Goldstein LI, Tong MJ, Busuttil RW.

Liver Transpl. 2009 Nov;15(11):1525-34. doi: 10.1002/lt.21882.

10.

Combined prophylaxis might still be better than monoprophylaxis with entecavir following liver transplantation for hepatitis B.

Samuel D, Roche B.

Gastroenterology. 2012 Jan;142(1):e34; author reply e34-5. doi: 10.1053/j.gastro.2011.09.052. Epub 2011 Nov 21. No abstract available.

PMID:
22115628
11.

A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection.

Li N, Lai EC, Shi J, Guo WX, Xue J, Huang B, Lau WY, Wu MC, Cheng SQ.

Ann Surg Oncol. 2010 Jan;17(1):179-85. doi: 10.1245/s10434-009-0694-z. Epub 2009 Aug 29.

PMID:
19727956
12.

Sustained low hepatitis B viral load predicts good outcome after curative resection in patients with hepatocellular carcinoma.

An HJ, Jang JW, Bae SH, Choi JY, Cho SH, Yoon SK, Han JY, Lee KH, Kim DG, Jung ES.

J Gastroenterol Hepatol. 2010 Dec;25(12):1876-82. doi: 10.1111/j.1440-1746.2010.06416.x.

PMID:
21092000
13.

Infections and organ transplantation: new challenges for prevention and treatment of hepatitis C virus.

Burra P, De Martin E.

Transplant Proc. 2011 Jul-Aug;43(6):2455-6. doi: 10.1016/j.transproceed.2011.06.017. Review.

PMID:
21839292
14.

Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?

Lok AS.

J Gastroenterol Hepatol. 2011 Feb;26(2):221-7. doi: 10.1111/j.1440-1746.2010.06576.x.

PMID:
21070361
15.

Hepatitis B virus infection and liver transplantation.

Kennedy M, Alexopoulos SP.

Curr Opin Organ Transplant. 2010 Jun;15(3):310-5. doi: 10.1097/MOT.0b013e32833991f8. Review.

PMID:
20445447
16.

Antiviral therapy after curative resection for patients with hepatitis B-related hepatocellular carcinoma.

Chong CC, Lai PB.

Br J Surg. 2013 May;100(6):724-5. doi: 10.1002/bjs.9105. Epub 2013 Mar 8. No abstract available.

PMID:
23475744
17.

Effect of antiviral treatment with nucleotide/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: a two-stage longitudinal clinical study.

Yin J, Li N, Han Y, Xue J, Deng Y, Shi J, Guo W, Zhang H, Wang H, Cheng S, Cao G.

J Clin Oncol. 2013 Oct 10;31(29):3647-55. doi: 10.1200/JCO.2012.48.5896. Epub 2013 Sep 3. Erratum in: J Clin Oncol. 2013 Nov 10;31(32):4167. J Clin Oncol. 2014 May 1;32(13):1386-7.

PMID:
24002499
18.

Evaluation of current treatment recommendations for chronic hepatitis B: a 2011 update.

Tong MJ, Hsu L, Chang PW, Blatt LM.

J Gastroenterol Hepatol. 2011 May;26(5):829-35. doi: 10.1111/j.1440-1746.2011.06623.x.

PMID:
21214888
19.

Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation.

Woo HY, Choi JY, Jang JW, You CR, Bae SH, Yoon SK, Yang JM, Choi SW, Han NI, Kim DG.

J Med Virol. 2008 Nov;80(11):1891-9. doi: 10.1002/jmv.21324.

PMID:
18814257

Supplemental Content

Support Center